Back to Results
First PageMeta Content
Health / Pharmaceutical industry / Food and Drug Administration / Pharmacology / Drug safety / Investigational New Drug / Clinical trial / Investigational Device Exemption / Title 21 of the Code of Federal Regulations / Research / Clinical research / Medicine


Federal Register / Vol. 72, No[removed]Thursday, May 10, [removed]Notices Dated: May 4, 2007. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. E7–9056 Filed 5–9–07; 8:45 am]
Add to Reading List

Open Document

File Size: 45,79 KB

Share Result on Facebook

City

Rockville / /

IndustryTerm

telephone requests / biological products / /

Organization

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration / U.S.C. Chapter / HRSA Reports Clearance Office / office of Critical VerDate / office of Management and Budget / Food and Drug Administration / HRSA office of Women / office of Critical Path Programs / DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources / Division of Dockets Management / Health Resources and Services Administration / Services Administration / Availability AGENCY / /

Person

Jeffrey Shuren / Terrie L. Crescenzi / /

/

Position

investigator / Assistant Commissioner for Policy / Commissioner / /

ProvinceOrState

Maryland / /

URL

www.fda.gov/ohrms / http /

SocialTag